Evidence map›Paper›PMID 28657755›Full record

ArticleNano letters2017

Simultaneous Enhancement of Photoluminescence, MRI Relaxivity, and CT Contrast by Tuning the Interfacial Layer of Lanthanide Heteroepitaxial Nanoparticles.

Sha He, Noah J J Johnson, Viet Anh Nguyen Huu, Esther Cory, Yuran Huang, Robert L Sah, Jesse V Jokerst, Adah Almutairi

Abstract read
In one paragraph

Article in Nano letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sha HeDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.
Noah J J JohnsonDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.ORCID 0000-0002-0721-3186
Viet Anh Nguyen HuuDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.
Esther CoryDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.
Yuran HuangDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.
Robert L SahDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.
Jesse V JokerstDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.ORCID 0000-0003-2829-6408
Adah AlmutairiDepartment of NanoEngineering, Jacobs School of Engineering, ‡Skaggs School of Pharmacy and Pharmaceutical Sciences, §Department of Bioengineering, Jacobs School of Engineering, ∥Materials Science and Engineering Program, ⊥Department of Orthopaedic Surgery, University of California San Diego , 9500 Gilman Dr., La Jolla, California 92093, United States.ORCID 0000-0001-5339-0207
University of California San Diego · US

Funding

TISSUE ACQUISITION, MORPHOLOGY, AND CELL CULTUREP01AG007996 · NIA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI D'LIMA, DARRYL D. · 1989 to 2016
$26.0M
Therapeutic Drug Monitoring with a Wearable Ultrasound-based SensorDP2HL137187 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOKERST, JESSE VINCENT · 2016 to 2019
$2.7M
Biomaterial enhancement of stem cell transplant efficacy for macular degenerationR01EY024134 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALMUTAIRI, ADAH, ZHANG, KANG · 2014 to 2016
$1.1M
A Therapeutic Tool for Ultrasound-Guided Stem Cell TherapyR00HL117048 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOKERST, JESSE VINCENT · 2015 to 2017
$747k
A Therapeutic Tool for ULtrasound-Guided Stem Cell TherapyK99HL117048 · NHLBI · STANFORD UNIVERSITY · PI JOKERST, JESSE VINCENT · 2014 to 2015
$265k
NEI NIH HHS R01 EY024134NHLBI NIH HHS DP2 HL137187NHLBI NIH HHS K99 HL117048NHLBI NIH HHS R00 HL117048NIA NIH HHS P01 AG007996
6 · The paper itself

Abstract

Nanoparticle (NP) based exogenous contrast agents assist biomedical imaging by enhancing the target visibility against the background. However, it is challenging to design a single type of contrast agents that are simultaneously suitable for various imaging modalities. The simple integration of different components into a single NP contrast agent does not guarantee the optimized properties of each individual components. Herein, we describe lanthanide-based core-shell-shell (CSS) NPs as triple-modal contrast agents that have concurrently enhanced performance compared to their individual components in photoluminescence (PL) imaging, magnetic resonance imaging (MRI), and computed tomography (CT). The key to simultaneous enhancement of PL intensity, MRI r

Indexed as

Contrast MediaLanthanoid Series ElementsLightLuminescent MeasurementsMagnetic Resonance ImagingMultimodal ImagingNanoshellsParticle SizePhysical PhenomenaSurface PropertiesTomography, X-Ray ComputedContrast MediaLanthanoid Series Elementscomputed tomographyContrast agentepitaxylanthanide nanoparticlesmagnetic resonance imagingphotoluminescence imaging

Identifiers

PMID28657755
PMCPMC5612482
OpenAlexW2732286515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.